Serotonin Reuptake Inhibitors and Risk of Abnormal Bleeding

被引：39

作者：

Andrade, Chittaranjan ^{[1
]}

Sharma, Eesha ^{[2
]}

机构：

[1] Natl Inst Mental Hlth & Neurosci, Dept Psychopharmacol, Bangalore 560029, Karnataka, India

[2] King Georges Med Univ, Dept Psychiat, Lucknow 226003, Uttar Pradesh, India

来源：

PSYCHIATRIC CLINICS OF NORTH AMERICA | 2016年 / 39卷 / 03期

关键词：

Antidepressant; Serotonin reuptake inhibitor; Selective serotonin reuptake inhibitor; Bleeding; Postpartum hemorrhage; Intracranial hemorrhage; Nonsteroidal anti-inflammatory drugs; Antiplatelet drugs; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; POPULATION-BASED COHORT; POSTPARTUM HEMORRHAGE; PREADOLESCENT GIRL; ANTIDEPRESSANTS; METAANALYSIS; STROKE; SERTRALINE; THERAPY; SURGERY;

D O I：

10.1016/j.psc.2016.04.010

中图分类号：

R749 [精神病学];

学科分类号：

100205 ;

摘要：

Serotonin reuptake inhibitors (SRIs) increase the risk of abnormal bleeding by lowering platelet serotonin and hence the efficiency of platelet-driven hemostasis; by increasing gastric acidity and possibly gastric ulceration; and by other mechanisms. The upper gastrointestinal tract is the commonest site of SRI-related abnormal bleeding; bleeding at this location may be increased by concurrent nonsteroidal anti-inflammatory drug therapy and by treatment with antiplatelet or anticoagulant drugs. Bleeding at this location may be reduced by concurrent administration of acid-suppressing drugs.

引用

页码：413 / +

页数：15

共 50 条

[11] Bleeding and selective serotonin reuptake inhibitors in childhood and adolescence
Lake, MB
Birmaher, B
Wassick, S
Mathos, K
Yelovich, K
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2000, 10 (01) : 35 - 38
[12] Risk of abnormal uterine bleeding associated with high-affinity compared with low-affinity serotonin and norepinephrine reuptake inhibitors
Engler, Julie
Filliter, Christopher
Montastruc, Francois
Abenhaim, Haim
Rej, Soham
Renoux, Christel
JOURNAL OF AFFECTIVE DISORDERS, 2024, 350 : 813 - 821
[13] Selective Serotonin Reuptake Inhibitors and Serotonin-Norepinephrine Reuptake Inhibitors Are Not Associated With Bleeding or Transfusion in Cardiac Surgical Patients
Smith, Mark M.
Smith, Bradford B.
Lahr, Brian D.
Nuttall, Gregory A.
Mauermann, William J.
Weister, Timothy J.
Dearani, Joseph A.
Barbara, David W.
ANESTHESIA AND ANALGESIA, 2018, 126 (06): : 1859 - 1866
[14] Rivaroxaban and selective serotonin reuptake inhibitors: Bleeding risk resulting from their concomitant use
Angel Bruni-Montero, Miguel
Manuel Caro-Teller, Jose
Antonio Hernandez-Ramos, Jose
Rosas-Espinoza, Cristian
Canales-Siguero, Dolores
Miguel Ferrari-Piquero, Jose
FARMACIA HOSPITALARIA, 2022, 46 (01) : 10 - 14
[15] Did Serotonin Reuptake Inhibitors (SRIs) associated to antiplatelet drugs increase the risk of bleeding?
Divouron, R.
Decisier, M.
Montastruc, J. L.
Bagheri, H.
FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2009, 23 : 103 - 103
[16] Use of Selective Serotonin Reuptake Inhibitors Antidepressants and Bleeding Risk in Breast Cosmetic Surgery
Filipe Volpe Basile
Antonio Roberto Basile
Vinicius Volpe Basile
Aesthetic Plastic Surgery, 2013, 37 : 561 - 566
[17] Selective serotonin reuptake inhibitors related bleeding risk: case report and review of literature
Boccatonda, Andrea
D'Ardes, Damiano
Guagnano, Maria Teresa
Cipollone, Francesco
Santilli, Francesca
EMERGENCY CARE JOURNAL, 2023, 19 (03)
[18] Selective serotonin reuptake inhibitors (SSRIs) and risk of upper gastrointestinal bleeding: Confusion or confounding?
Yuan, YH
Hunt, RH
GASTROENTEROLOGY, 2004, 126 (04) : A192 - A192
[19] Selective Serotonin Reuptake Inhibitors Are Associated With a Modest Increase in the Risk of Upper Gastrointestinal Bleeding
Targownik, Laura E.
Bolton, James M.
Metge, Colleen J.
Leung, Stella
Sareen, Jitender
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2009, 104 (06): : 1475 - 1482
[20] Are selective serotonin reuptake inhibitors (SSRIs) a risk factor for post-polypectomy bleeding?
Katsinelos, P.
Gkagkalis, S.
Chatzimavroudis, G.
Zavos, C.
Kountouras, J.
ENDOSCOPY, 2013, 45 (08) : 681 - 681

← 1 2 3 4 5 →